Comments on "High efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in Black adults in the United States, including those with pre-existing HIV resistance and suboptimal adherence".
第一作者:
Enagnon Kazali,Alidjinou
第一单位:
Laboratoire de Virologie, Univ Lille, CHU de Lille, Lille, France.
作者:
医学主题词
成年人(Adult);人类(Humans);腺嘌呤(Adenine);抗HIV药(Anti-HIV Agents);复方合剂(Drug Combinations);抗药性, 病毒(Drug Resistance, Viral);杂环化合物, 3环(Heterocyclic Compounds, 3-Ring);HIV感染(HIV Infections);哌嗪类(Piperazines);吡啶酮类(Pyridones);治疗结果(Treatment Outcome);美国(United States)
DOI
10.1002/jmv.29950
PMID
39350643
发布时间
2025-01-03
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



